Ventavis 10microgramsml nebuliser solution 2ml ampoules

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Iloprost trometamol

Available from:

Schering Health Care Ltd

INN (International Name):

Iloprost trometamol

Dosage:

10microgram/1ml

Pharmaceutical form:

Nebuliser liquid

Administration route:

Inhalation

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF:

Patient Information leaflet

v017_0
Page 1 of 12
Due to regulatory changes, the content of the following Patient
Information Leaflet may vary from the one found in your medicine pack.
Please compare the 'Leaflet prepared/revised date' towards the end of
the leaflet to establish if there have been any changes.
If you have any doubts or queries about your medication, please
contact
your doctor or pharmacist.
PACKAGE LEAFLET: INFORMATION FOR THE USER
VENTAVIS 10 MICROGRAM/ML NEBULISER SOLUTION
Iloprost
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Ventavis is and what it is used for
2.
What you need to know before you use Ventavis
3.
How to use Ventavis
4.
Possible side effects
5.
How to store Ventavis
6.
Contents of the pack and other information
1.
WHAT VENTAVIS IS AND WHAT IT IS USED FOR
WHAT VENTAVIS IS
The active substance of Ventavis is iloprost. It imitates a natural
substance in the body called
prostacyclin. Ventavis inhibits unwanted blocking or narrowing of
blood vessels and allows more
blood to flow through the vessels.
v017_0
Page 2 of 12
WHAT VENTAVIS IS USED FOR
Ventavis is used to treat moderate cases of primary pulmonary
hypertension (PPH) in adult patients.
PPH is a category of pulmonary hypertension where the cause of the
high blood pressure is not
known.
This is a condition where blood pressure is too high in the blood
vessels between the heart and the
lungs.
Ventavis is used to improve exercise capacity (the ability to carry
out physical activity) and
symptoms.
HOW VENTAVIS WORKS
Breathing in

Summary of Product characteristics

VENTAVIS 10 MICROGRAM/ML NEBULISER SOLUTION
Summary of Product Characteristics Updated 14-Aug-2017 | Bayer plc
1. Name of the medicinal product
Ventavis 10 microgram/ml nebuliser solution
Ventavis 20 microgram/ml nebuliser solution
2. Qualitative and quantitative composition
Ventavis 10 microgram/ml nebuliser solution
1 ml solution contains 10 microgram iloprost (as iloprost trometamol).
Each ampoule with 1 ml solution contains 10 microgram iloprost.
Each ampoule with 2 ml solution contains 20 microgram iloprost.
Ventavis 20 microgram/ml nebuliser solution
1 ml solution contains 20 microgram iloprost (as iloprost trometamol).
Each ampoule with 1 ml solution contains 20 microgram iloprost.
Excipient with known effect:
• Ventavis 10 microgram/ml:
Each ml contains 0.81 mg ethanol 96% (equivalent to 0.75 mg ethanol)
• Ventavis 20 microgram/ml:
Each ml contains 1.62 mg ethanol 96% (equivalent to 1.50 mg ethanol)
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Nebuliser solution.
Ventavis 10 microgram/ml nebuliser solution
Clear, colourless solution.
Ventavis 20 microgram/ml nebuliser solution
Clear, colourless to slightly yellowish solution.
4. Clinical particulars
4.1 Therapeutic indications
Treatment of adult patients with primary pulmonary hypertension,
classified as NYHA functional class
III, to improve exercise capacity and symptoms.
4.2 Posology and method of administration
DRUG PRODUCT
SUITABLE INHALATION DEVICE (NEBULISER) TO BE USED
VENTAVIS 10 MICROGRAM/ML
BREELIB
I-NEB AAD
VENTA-NEB
VENTAVIS 20 MICROGRAM/ML
BREELIB
I-NEB AAD
Ventavis should only be initiated and monitored by a physician
experienced in the treatment of
pulmonary hypertension.
Posology
_Dose per inhalation session_
At initiation of Ventavis treatment the first inhaled dose should be
2.5 microgram iloprost as delivered at
the mouthpiece of the nebuliser. If this dose is well tolerated,
dosing should be increased to 5 microgram
iloprost and maintained at that dose. In case of poor tolerability of
the 5 microgram dos